Can Innovative Value-Based Pricing Models Relieve Pricing Pressure in the Medical Device Industry?

article image
ARTICLE SUMMARY:

Hospital consolidation is increasing purchasing leverage through greater pricing transparency and that has substantiated a need for new pricing models in medtech. There are challenges associated with several emerging pricing models; regardless, manufacturers will need to develop innovative approaches to maximize opportunity while minimizing risk. By Matthew Majewski and Kira Gordon, CRA’s Life Sciences Practice

Much like the rest of the healthcare sector, the medical device industry is currently experiencing a period of increasing pricing pressure.  As hospitals continue to consolidate—more than 60% of community hospitals now belong to a health system—their ability to negotiate has improved, particularly as it relates to the prices they pay for pharmaceuticals and medical devices.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.


Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite

Questions?

We're here to help! Please contact us at: